Colombia issues a compulsory license on patents for the HIV drug Dolutegravir

This is the 44 page decision:

NC_534_Licencia_obligatoria_aceptada

Arianna Schouten has a summary of the decision in English here:

23Apr2024-DecisionColombiaCLdolutegravir